Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SRT
5276
DELISTED
Startek Inc.
SRT
| $94K | ﹤0.01% |
14,480
-14,025
| -49% | -$80K |
2013 Q2
1 quarter
|
|
|
EQM
5277
CALL
DELISTED
EQM Midstream Partners, LP
EQM
| $94K | ﹤0.01% |
+1,900
| New | +$89.3K |
2013 Q3
0 quarters
|
|
|
KZ
5278
DELISTED
KongZhong Corporation
KZ
| $94K | ﹤0.01% |
7,184
-31,038
| -81% | -$308K |
2013 Q2
1 quarter
|
|
|
HTS
5279
PUT
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $94K | ﹤0.01% |
5,000
-8,500
| -63% | -$171K |
2013 Q2
1 quarter
|
|
5280
American Homes 4 Rent
AMH
$10.9B
| $93K | ﹤0.01% |
+5,774
| New | +$92.5K |
2013 Q3
0 quarters
|
|
5281
CALL
Exelixis
EXEL
$14.5B
| $93K | ﹤0.01% |
16,000
-7,600
| -32% | -$39.3K |
2013 Q2
1 quarter
|
|
5282
CALL
Ezcorp Inc
EZPW
$1.86B
| $93K | ﹤0.01% |
5,500
-5,600
| -50% | -$100K |
2013 Q2
1 quarter
|
|
|
TNGO
5283
PUT
DELISTED
Tangoe, Inc.
TNGO
| $93K | ﹤0.01% |
3,900
+3,400
| +680% | +$66.1K |
2013 Q2
1 quarter
|
|
|
PDLI
5284
CALL
DELISTED
PDL BioPharma, Inc.
PDLI
| $93K | ﹤0.01% |
11,700
+7,100
| +154% | +$57.1K |
2013 Q2
1 quarter
|
|
|
LLEN
5285
CALL
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
| $93K | ﹤0.01% |
+73,200
| New | +$199K |
2013 Q3
0 quarters
|
|
5286
PUT
McEwen Inc
MUX
$1.09B
| $92K | ﹤0.01% |
3,820
-4,510
| -54% | -$102K |
2013 Q2
1 quarter
|
|
5287
CALL
Oxford Square Capital
OXSQ
$138M
| $92K | ﹤0.01% |
9,400
+4,000
| +74% | +$39.3K |
2013 Q2
1 quarter
|
|
5288
PetMed Express
PETS
$29.5M
| $92K | ﹤0.01% |
5,638
-1,593
| -22% | -$24.8K |
2013 Q2
1 quarter
|
|
|
PGNX
5289
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $92K | ﹤0.01% |
18,300
+7,100
| +63% | +$38.5K |
2013 Q2
1 quarter
|
|
|
UCFC
5290
DELISTED
United Community Financial Corp
UCFC
| $92K | ﹤0.01% |
+23,794
| New | +$102K |
2013 Q3
0 quarters
|
|
|
SEP
5291
PUT
DELISTED
Spectra Engy Parters Lp
SEP
| $92K | ﹤0.01% |
2,100
-900
| -30% | -$39.2K |
2013 Q2
1 quarter
|
|
|
NES
5292
CALL
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
| $92K | ﹤0.01% |
4,010
+1,150
| +40% | +$32.5K |
2013 Q2
1 quarter
|
|
5293
CALL
Allot
ALLT
$416M
| $91K | ﹤0.01% |
7,200
-9,300
| -56% | -$124K |
2013 Q2
1 quarter
|
|
5294
Alliance Resource Partners
ARLP
$3.16B
| $91K | ﹤0.01% |
2,442
-240
| -9% | -$9.03K |
2013 Q2
1 quarter
|
|
|
ATCO
5295
PUT
DELISTED
Atlas Corp.
ATCO
| $91K | ﹤0.01% |
3,700
-32,600
| -90% | -$708K |
2013 Q2
1 quarter
|
|
|
PRKR
5296
PUT
DELISTED
Parkervision Inc
PRKR
| $91K | ﹤0.01% |
+2,730
| New | +$109K |
2013 Q3
0 quarters
|
|
|
SKS
5297
CALL
DELISTED
SAKS INCORPORATED
SKS
| $91K | ﹤0.01% |
5,700
-43,100
| -88% | -$671K |
2013 Q2
1 quarter
|
|
5298
CALL
Gran Tierra Energy
GTE
$369M
| $90K | ﹤0.01% |
1,270
+680
| +115% | +$44.6K |
2013 Q2
1 quarter
|
|
|
CMD
5299
DELISTED
Cantel Medical Corporation
CMD
| $90K | ﹤0.01% |
+2,833
| New | +$75.3K |
2013 Q3
0 quarters
|
|
|
SKUL
5300
CALL
DELISTED
SKULLCANDY INC
SKUL
| $90K | ﹤0.01% |
14,600
+12,400
| +564% | +$69.3K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.